Suh D C, Lacy C R, Barone J A, Moylan D, Kostis J B
College of Pharmacy, Rutgers--The State University of New Jersey, Piscataway 08854, USA.
Clin Ther. 1999 Jul;21(7):1241-53. doi: 10.1016/S0149-2918(00)80026-0.
Between 1970 and 1995, national prescription drug expenditures and Medicaid drug expenditures increased proportionately less than did total health care expenditures and total Medicaid expenditures, respectively, although they increased to a greater extent than did expenditures in other sectors of the economy. General inflation, which cannot be controlled by health care policy, has been the major factor contributing to the growth in national prescription drug expenditures. Other contributors were population growth, increases in per capita prescription use, increases in per-prescription intensity (ie, real drug expenditures), and the fact that prescription drug prices exceeded general inflation. Medicaid drug expenditures have increased mainly because of growth in the number of drug recipients, increases in prescription drug prices, and economy-wide inflation.
1970年至1995年间,全国处方药支出和医疗补助处方药支出分别比总体医疗保健支出和总体医疗补助支出增长的比例要小,尽管它们的增长幅度比经济其他部门的支出增长幅度更大。无法通过医疗保健政策控制的一般通货膨胀一直是全国处方药支出增长的主要因素。其他因素包括人口增长、人均处方药使用量增加、每次处方用药强度增加(即实际药品支出)以及处方药价格超过一般通货膨胀率这一事实。医疗补助处方药支出增加主要是由于药品受助者数量增加、处方药价格上涨以及整个经济的通货膨胀。